4.410SEK+12.50%Mkt Cap: 101.38M SEKP/E: —Last update: 2026-05-13
AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample prepara…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)-5.99
PEG—
P/B6.22
P/S9.72
EV/EBITDA-8.85
EV/Revenue9.11
EPS (TTM)-0.64
EPS (Forward)-0.80
Cash Flow & Leverage
FCF Yield-12.60%
FCF Margin-122.49%
Operating CF-16.78M SEK
CapEx (TTM)488.00K SEK
Net Debt/EBITDA0.59
Net Debt-6.29M SEK
Technical
SMA 503.268 (+34.9%)
SMA 2002.966 (+48.7%)
Beta0.11
S&P 52W Chg24.23%
Avg Vol (30d)46.85K
Avg Vol (10d)42.73K
Technical Indicators
RSI (14)70.8
MACD0.2715
MACD Signal0.2573
MACD Hist.+0.0142
BB Upper4.514 SEK
BB Middle3.707 SEK
BB Lower2.900 SEK
BB Width43.52%
ATR (14)0.3978 SEK
Vol Ratio (20d)1.01x
52W Range
2.03099% of range4.440
52W High4.440 SEK
52W Low2.030 SEK
Profitability
Gross Margin98.38%
EBITDA Margin-103.03%
Profit Margin-177.34%
Oper. Margin-87.29%
ROE-74.55%
ROA-67.92%
Revenue Growth-11.60%
Earnings Growth—
Balance Sheet
Debt/Equity—
Current Ratio8.19
Quick Ratio4.22
Book Value/Sh0.7700 SEK
Cash/Share0.2970 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Ownership
Shares Out.21.16M
Float16.91M
Insiders40.48%
Institutions2.34%
Analyst Consensus
Rating—
Target (Mean)10.00 SEK
Target Range10.00 SEK – 10.00 SEK
# Analysts1
Company
Market Cap101.38M SEK
Enterprise Value95.08M SEK
Revenue (TTM)10.43M SEK
Gross Profit6.74M SEK
Net Income (TTM)-12.15M SEK
Revenue/Share0.5530 SEK
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
Last Price4.410 SEK
CountrySE
SectorHealthcare
IndustryBiotechnology
ISIN—